FDA Declines to Approve Y-mAbs's Pediatric Cancer Drug
The health regulator on Thursday declined to approve a treatment from Y-mAbs Therapeutics for a rare form of nerve cancer in pediatric patients, dragging the company's shares down 16% in extended trading. Reuters Health Information
High Febrile Neutropenia Risk With Docetaxel in Prostate Cancer
The risk is high enough to consider routine febrile neutropenia prophylaxis in patients with metastatic castration-resistant disease. The study was published as a preprint and has not been peer reviewed. First Look
Cancer Research Falls Short on Data and Code Sharing
Data were made available in only 16% of oncology articles randomly selected for analysis, and only 1% complied with best practices for data and code sharing. Medscape Medical News
History of the FDA: An Oncologist Gives an Inside Look
In his new book, Mikkael Sekeres, MD, reflects on the history of the FDA and how the agency regulates drug approvals. Medscape Medical News
AstraZeneca Boosts Cancer Portfolio With $320 Million Neogene Deal
AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments. Reuters Health Information
Lung Cancer Screening Pushes 20-Year Survival Rate to 80%
Results of a large, international study show the benefit of annual, low-dose CT scans for those diagnosed early persists at 20 years. Medscape Medical News
'Something Good After Tragic Loss': Donating Brain Cancer Tissue
Families of children with brain cancer are often unaware of the option of postmortem tissue donation, and many have expressed resentment that they had not been informed. Medscape Medical News
Transgender Patients on Hormone Therapy Require Monitoring
Because of their increased risk for death, compared with the general population, transgender patients on hormone therapy need cardiovascular and cancer monitoring, according to experts. Medscape Medical News
Laser Pioneer Reflects on the Future of Robots in Dermatology
A Mohs surgery robot with image-guided laser ablation would 'launch a sea change in the whole field of surgical oncology,' says Dr R. Rox Anderson. Medscape Medical News
FDA Requests More Restrictions on Ovarian Cancer Drugs
The limits on second-line prescribing for one of the drugs, rucaparib, could put the company's financial future at risk, a company report shows. Medscape Medical News
